[Federal Register Volume 79, Number 128 (Thursday, July 3, 2014)]
[Notices]
[Pages 38049-38050]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-15681]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of National Institutes of Health Workshop on the 
Enrollment and Retention of Participants in NIH-Funded Clinical Trials

SUMMARY: The National Institutes of Health (NIH) is conducting a 
workshop with interested stakeholders in order to hear perspectives on 
issues related to the enrollment and retention of research participants 
in NIH-funded clinical

[[Page 38050]]

trials. The workshop will be open to the public.

DATES: The workshop will be held on Friday, July 25, 2014, from 8:15 
a.m. to 5:45 p.m., in the NIH Porter Neuroscience Research Center, 35 
Convent Drive, Bethesda, Maryland 20892.

FOR FURTHER INFORMATION CONTACT: Registration and workshop information 
is available at the NIH Office of Science Policy (OSP) Web site (http://osp.od.nih.gov). OSP's mailing address is 6705 Rockledge Drive, Suite 
750, Bethesda, MD 20892. Additional questions about the workshop may be 
directed to the office by calling 301-436-9838, or by emailing [email protected].

SUPPLEMENTARY INFORMATION: The NIH's ability to improve the efficiency 
and effectiveness of its clinical trials is critical to the agency's 
mission to foster research strategies that protect and improve human 
health. The goal of the workshop is to explore strategies to enhance 
enrollment, recruitment, and retention of participants in clinical 
trials.
    The meeting agenda covers a range of topics related to the 
enrollment and retention of clinical trial participants, including: 
current challenges in clinical trial participant enrollment; cultural 
and social considerations in clinical trial participant enrollment and 
outreach; recruitment and outreach considerations for underrepresented 
and vulnerable populations; roles for public foundations in clinical 
trial participant enrollment and retention; public private partnerships 
to improve patient and public awareness and engagement; models to 
identify and support clinical trial participants; and strategies for 
tracking and monitoring clinical trial participation and post-trial 
communication. A full meeting agenda will be available prior to the 
workshop at the NIH OSP Web site (http://od.osp.nih.gov).
    The meeting will be open to the public, with attendance limited to 
the space available. Instructions for preregistration (required) are 
available on the NIH OSP Web site (http://osp.od.nih.gov). Individuals 
who plan to attend and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should notify the 
Contact Person listed below in advance of the meeting.
    In the interest of security, the NIH has instituted stringent 
procedures for entrance onto its Bethesda campus. All vehicles, 
including taxis, hotel, and airport shuttles will be inspected before 
being allowed on campus. Visitors will be asked to show one form of 
identification (for example, a government-issued photo ID, driver's 
license, or passport) and to state the purpose of their visit. For more 
information about the security measures at the NIH, please visit the 
Web site at http://www.nih.gov/about/visitorsecurity.htm.

    Dated: June 27, 2014.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2014-15681 Filed 7-2-14; 8:45 am]
BILLING CODE 4140-01-P